• Company type:
      • Research & Development
    • Year founded:
    • 1997
    • Employees (at the site):
    • 94
    • Turnover range:
    • <5m EUR
    • Products/services:
    • Headquartered in Planegg-Martinsried near Munich/Germany, 4SC is an innovative biotech company with a strong focus on research and development.
      4SC discovers and develops targeted small molecule drugs for the treatment of cancer and autoimmune diseases in indications with a high unmet medical need and major economic potential.

      Targeted Therapies; Oncology; cancer; liver cancer; colorectal cancer; Hodgkin's Lymphoma; autoimmune diseases; inflammatory bowel disease; chronic obstructive pulmonary disease; Biotechnological therapeutics

    • Core competencies:
    • 4SC's core competencies include research and development of targeted therapies for the treatment of cancer and autoimmune diseases. The 4SC in-house research team focuses on the underlying mechanisms of pathways in uncontrolled cell signaling. In addition to developing novel therapies, 4SC researchers identify the mechanisms of action of the company’s clinical portfolio, including vidofludimus and resminostat.
      The research team at 4SC is involved from 4SC’s proprietary in silico screening technology to medicinal chemistry, as well as in vitro and in vivo pharmacology and ADMET studies. The team therefore covers the complete compound discovery and development.

    • Language skills:
    • English
    • Key Tech / section:
      • Biotechnology: Bioinformatics and cheminformatics
      • Biotechnology: Preclinical development
      • Biotechnology: Therapeutic drug development
    • Industries NACE:
      • 72: Scientific research and development
      • 21.20: Manufacture of pharmaceutical preparations
    • Certification:
    • not available

    • Sales markets - target industries:
    • biopharmazeutische Industrie
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Dipl.-Kfm. Enno Spillner (Mr.)
      - Management

      Dr. Daniel Vitt (Mr.)
      - Management
      - Research & development

      Dr. Bernd Hentsch (Mr.)
      - Management
      - Research & development

      Dr. Ulrich Dauer (Mr.)
      - Management